ID solutions develops and markets complete solutions from the extraction of circulating DNA to its quantification/normalization and genotyping for cancer monitoring. Our goals are to improve the diagnostic in oncology analysis and to offer a comprehensive and innovative solution (pre-analytical and analytical) for reliable, fast, normalized and standardized results. Our assays give its full potential to DNA as a circulating biomarker, are performed starting by a simple blood drawn (liquid biopsy) and use real time quantitative PCR, NGS and the latest digital PCR technologies.